81TiP NVL-655, a selective anaplastic lymphoma kinase (ALK) inhibitor, in patients with advanced ALK-positive solid tumors: The phase I/II ALKOVE-1 study

Subjects

Subjects :

Pulmonary and Respiratory Medicine
Oncology

Details

ISSN :

15560864

Volume :

18

Database :

OpenAIRE

Journal :

Journal of Thoracic Oncology

Accession number :

edsair.doi...........7e43d67fd1f7d057054578e3ab51d64b

Full Text :

https://doi.org/10.1016/s1556-0864(23)00335-0